Gregory Naeve, Ph.D.

Gregory Naeve joined Bellicum in August 2017 as Chief Business Officer to lead product and portfolio strategy as well as business development for the Company. Previously, Dr. Naeve served as the ImmunoOncology & Cell Therapy Lead for Pfizer’s External Research and Development Unit. During his tenure, he was a key member of the executive team responsible … Read More


Rosie Williams, CPA

Rosie Williams joined Bellicum in 2014 and serves as Vice President of Finance and Controller.  She is a Certified Public Accountant with over 30 years of experience in finance and accounting.  She began her career working in the public accounting field at Arthur Andersen and later held positions of increasing responsibility with various companies and industries, including … Read More


Aaron Foster, Ph.D.

Aaron Foster is Vice President of Product Discovery at Bellicum Pharmaceuticals. He leads the CAR and TCR gene-modified T cell programs that are developing systems for controlling T cell behavior in vivo using molecular switch technology. Prior to joining Bellicum in 2012, Dr. Foster was an Assistant Professor at Baylor College of Medicine at the Center … Read More


Jim Daly

Mr. Daly has over 30 years of experience leading U.S. and global businesses in the biopharmaceutical industry and currently serves as a Director of ACADIA Pharmaceuticals, Halozyme Therapeutics, and Chimerix, Inc. Most recently, Mr. Daly served as Executive Vice President and Chief Commercial Officer at Incyte Corporation from 2012 to 2015, where he was instrumental in … Read More


Alan K. Smith, Ph.D.

Alan Smith, Executive Vice President, Technical Operations, joined Bellicum in October 2015. He has over 30 years of experience in R&D, Manufacturing and Quality roles in cellular therapeutics and previously served as Bellicum’s Senior Vice President of Manufacturing. Prior to that, Dr. Smith was Vice President of Research & Development and Cellular Therapeutics for LifeNet Health, … Read More


Scott Cullison

Scott Cullison joined Bellicum in August 2015 as Vice President of Commercial Planning and Program Management. He brings over 13 years of biotech and pharmaceutical industry experience, including expertise in business development, alliance management, product management, commercialization, R&D program leadership and strategic planning. Throughout his career, Mr. Cullison held positions of increasing responsibility at Targacept, … Read More


Steven Toler, Pharm.D., Ph.D.

Steve Toler joined Bellicum in May of 2015 as Vice President of Pharmaceutical Development. He has over 22 years of Pharmaceutical R&D experience, beginning his career with Pfizer in 1993. Most recently, Steve was Vice President of Translational Medicine at Targacept in Winston-Salem, North Carolina. Steve holds a Pharm.D. degree from Mercer University and a … Read More


Martha French

Martha French joined Bellicum in 2011 with over 25 years combined experience in biomedical research and regulatory affairs. As Director of Regulatory Affairs at InGeneron Inc., she was responsible for the management of European and US regulatory activities for medical devices that prepare autologous regenerative cell therapies at point of care. At Introgen Therapeutics, Martha … Read More


Anne Frese

Anne Frese joined Bellicum in March 2015 as Vice President of Human Resources. With over 25 years experience as a global HR leader, she has successfully crossed industry sectors, from engineering and technology to healthcare and consulting. Ms. Frese has led the function from start ups through transformations ensuring the HR strategies underpin and enable … Read More


Jon P. Stonehouse

Jon P. Stonehouse is currently President and Chief Executive Officer of BioCryst Pharmaceuticals, Inc., and has over 20 years of pharmaceutical executive experience. Prior to joining BioCryst in 2007, he served as Senior Vice President of Corporate Development at Merck KGaA. Among his accomplishments, he was responsible for leading the effort to develop a strategy … Read More